1. Sanna, S. et al. Fine Mapping of Five Loci Associated with Low-Density Lipoprotein Cholesterol Detects Variants That Double the Explained Heritability. PLOS Genetics 7, e1002198 (2011).
2. Willer, C. J. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274–1283 (2013).
3. Asselbergs, F. W. et al. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am. J. Hum. Genet. 91, 823–838 (2012).
4. Willer, C. J. et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nature Genetics 40, 161–169 (2008).
5. Chasman, D. I. et al. Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis. PLOS Genetics 5, e1000730 (2009).
6. Kathiresan, S. et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nature Genetics 40, 189–197 (2008).
7. Lu, X. et al. Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease. Nat. Genet. 49, 1722–1730 (2017).
8. Liu, D. J. et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat. Genet. 49, 1758–1766 (2017).
9. Hoffmann, T. J. et al. A large electronic-health-record-based genome-wide study of serum lipids. Nat. Genet. 50, 401–413 (2018).
10. Duncan, L. et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nature Communications 10, 3328 (2019).
11. Lewis, C. M. & Vassos, E. Polygenic risk scores: from research tools to clinical instruments. Genome Medicine 12, 44 (2020).
12. Gomez, F., Hirbo, J. & Tishkoff, S. A. Genetic Variation and Adaptation in Africa: Implications for Human Evolution and Disease. Cold Spring Harb Perspect Biol 6, a008524 (2014).
13. Turley, P. et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nature Genetics 50, 229–237 (2018).
14. Márquez-Luna, C., Loh, P.-R., South Asian Type 2 Diabetes (SAT2D) Consortium, SIGMA Type 2 Diabetes Consortium & Price, A. L. Multiethnic polygenic risk scores improve risk prediction in diverse populations. Genet Epidemiol 41, 811–823 (2017).
15. Bentley, A. R., Callier, S. L. & Rotimi, C. N. Evaluating the promise of inclusion of African ancestry populations in genomics. npj Genomic Medicine 5, 1–9 (2020).
16. Cavazos, T. B. & Witte, J. S. Inclusion of variants discovered from diverse populations improves polygenic risk score transferability. Human Genetics and Genomics Advances 2, 100017 (2021).
17. Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nature Genetics 51, 584–591 (2019).
18. Johnson, L., Zhu, J., Scott, E. R. & Wineinger, N. E. An Examination of the Relationship between Lipid Levels and Associated Genetic Markers across Racial/Ethnic Populations in the Multi-Ethnic Study of Atherosclerosis. PLOS ONE 10, e0126361 (2015).
19. Lucchese, B. Implications of African genetic diversity. Nature Reviews Nephrology 5, 663–663 (2009).
20. Yu, N. et al. Larger Genetic Differences Within Africans Than Between Africans and Eurasians. Genetics 161, 269–274 (2002).